View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
July 28, 2022

US medical devices industry sees a drop of 25% in deal activity in June 2022

By Carmen

US medical devices industry saw a drop of 25% in overall deal activity during June 2022, when compared with the last 12-month average, led by Evolent Health’s $462m acquisition of Implantable Provider Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 81 deals worth $1.6bn were announced in June 2022, compared with the 12-month average of 108 deals.

venture financing was the leading category in the month in terms of volume with 57 deals, which accounted for 70.4% of all deals.

In second place was M&A with 17 deals, followed by private equity with seven transactions, respectively accounting for 21% and 8.6% of overall deal activity in the US technology industry during the month.

In terms of value of deals, venture financing was the leading deal category in the US medical devices industry with total deals worth $767.6m, while M&A and private equity deals totalled $702.1m and $129.1m, respectively.

US medical devices industry deals in June 2022: Top deals

The top five medical devices industry deals accounted for 53.8% of the overall value during June 2022.

The combined value of the top five medical devices deals stood at $859.8m, against the overall value of $1.6bn recorded for the month.

The top five medical devices industry deals of June 2022 tracked by GlobalData were:

1) Evolent Health $462m acquisition deal with Implantable Provider Group

2) The $177.8m acquisition of Guardant Health AMEA by Guardant Health

3) Patient Square Capital $100m private equity deal with Eargo

4) The $60m venture financing of Aerin Medical by Ally Bridge Group,KCK Group,Orbimed Advisors and Questa Capital Management

5) Amplify Partners,B Capital Group and Felicis Ventures $60m venture financing deal with Mission Health Labs

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network